Dianosic

Dianosic company information, Employees & Contact Information

Explore related pages

Related company profiles:

Dianosic ambitions to become a leading company in solving challenges in patient’s adherence to medication. We provide an alternative to daily medication by designing a unique sustained intranasal drug delivery solution for respiratory and chronic central nervous system diseases.   Dianosic aims to fight against debilitating chronic diseases that affect millions of people. Our first focus is on chronic allergic rhinitis and chronic rhinosinusitis. Currently, 85% of allergic rhinitis patients are not compliant with their treatment. Furthermore, 20% to 25% of patients do not respond to first-line treatments. These medical challenges significantly impact patient’s quality of life.   We closely collaborate with healthcare professionals, including physicians in otorhinolaryngology (ENT) and neurosurgery. Our multidisciplinary team works hand in hand with them in order to design solutions that change physicians’ experience and offer patients minimally invasive and non-surgical options. Dianosic develops ARIS, a unique platform that benefits from proprietary drug-eluting, long-term resorbable polymer. Our unique concept is meant to deliver patient centric, “insert and forget” solutions, maximizing patient quality of life and addressing physicians’ needs in terms of efficacy, safety, ease of use and patient adherence to treatment. Click here to learn more about our solutions: https://bit.ly/3Tnagog   📞 For more information, please contact us via LinkedIn private message, by mail (contact@dianosic.com) or phone (+33 1 44 04 45 80).

Company Details

Employees
12
Founded
-
Address
8, Place De L'hôpital, Strasbourg,grand Est 67000,france
Phone
33144014580
Email
co****@****sic.com
Industry
Biotechnology Research
NAICS
Research and Development in Biotechnology (except Nanobiotechnology)
HQ
Strasbourg, Grand Est
Looking for a particular Dianosic employee's phone or email?

Dianosic Questions

News

Aptar Pharma and Dianosic Announce Exclusive Partnership to Advance the Active Resorbable Intranasal Scaffold Platform for the Treatment of Chronic Allergic Rhinitis and Chronic Rhinosinusitis - Business Wire

Aptar Pharma and Dianosic Announce Exclusive Partnership to Advance the Active Resorbable Intranasal Scaffold Platform for the Treatment of Chronic Allergic Rhinitis and Chronic Rhinosinusitis Business Wire

Aptar and Dianosic to develop ARIS technology for chronic nasal conditions - Medical Device Network

Aptar and Dianosic to develop ARIS technology for chronic nasal conditions Medical Device Network

Top Dianosic Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant